alexa
Reach Us +447482876457
Editor - Deling Kong | Nankai University | 23175
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Deling Kong

Deling Kong
Deling Kong
College of Life Science 
Nankai University; Director,
The Key Laboratory of Bioactive Materials, Ministry of Education,
School of Life Science
Nanklai University
China
Nankai University

Biography

Dr. Kong is a Professor of Biological Chemistry, Director of the Key Laboratory of Bioactive Materials, Ministry of education at Nankai University. His research interests focus on cardiovascular regenerative medicine, including stem cell treatment of myocardium infarction and vascular grafts. In stem cell therapy, his group use bioactive hydrogel to improve the survival of the implanted stem cells and regulate their differentiation and paracrine. They also use the molecular imaging technology to track the implanted cells and study the function mechanism. Their work in vascular grafts focuses on creation of multifunctional and bioactive scaffolds with ideal material properties that can facilitate rapid endothelialization, regeneration of functional smooth muscle layer, and maintain long-term patency. Dr. Kong won the Outstanding Youth Fund of NSFC in 2007. He won the 2nd class National Scientific Technology Progress Award of China in 2009, and the 2nd class Natural Science Award of Tianjin in 2010. He was elected to the Fellow of Biomaterials Science & Engineering (FBSE) in 2016. He has published more than 200 peer reviewed papers, which were cited over 3000 times. He is also holding more than 15 approved patents.

Research Interest

His research interests focus on cardiovascular regenerative medicine, including stem cell treatment of myocardium infarction and vascular grafts.

Certificate

Certificate
Leave Your Message 24x7
Top